rosuvastatin [orch, phsu]
Review [inpr]
Prevention [topp]
CARDIOVASCULAR [bdsy]
Disease [dsyn]
Health [idcn]
Women [popg]
Men [popg]
Normal [qlco]
Level [qlco]
Elevated [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
rosuvastatin [orch, phsu]
Crestor [orch, phsu]
R- [spco]
HMG-CoA reductase inhibitor [orch, phsu]
Statin [orch, phsu]
Lipid [lipd]
lowering [spco]
Anti-inflammatory effect [qlco]
Drug [phsu]
Various [irda]
Indications [idcn]
Including [ftcn]
Primary Prevention [topp]
Cardiovascular disease [dsyn]
Patients [podg]
Clinical [qlco]
Evidence [ftcn]
coronary heart disease [dsyn]
Increased [qnco]
Risk [qlco]
Cardiovascular disease [dsyn]
Based [ftcn]
Age [orga]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
mg/L [qnco]
One [qnco]
cardiovascular risk factor [dsyn]
Disease [dsyn]
Efficacy [qlco]
rosuvastatin [orch, phsu]
Health [idcn]
Women [popg]
Aged [orga]
Men [popg]
Aged [orga]
Normal [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Level [qlco]
Elevated [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
Large [qnco]
randomized [resa]
DOUBLE BLIND [resa]
Jupiter [geoa]
Trial [resa]
Relative [famg]
placebo [topp]
rosuvastatin [orch, phsu]
mg% [qnco]
Once daily [tmco]
median [spco]
Follow-up [fndg]
Reduced [qlco]
occurrence [ftcn]
First [qnco]
Major [qlco]
cardiovascular events [fndg]
Trial [resa]
Primary Endpoint [irda]
Between [spco]
Group [idcn]
rosuvastatin [orch, phsu]
Various [irda]
endpoints [qlco]
Including [ftcn]
Overall [inpr]
deaths [orgf]
End Point [qlco]
Venous Thromboembolism [patf]
rosuvastatin [orch, phsu]
More [ftcn]
effective [qlco]
placebo [topp]
Primary Endpoint [irda]
Result [ftcn]
Stratified [qlco]
Various [irda]
baseline [bodm]
Factor [ftcn]
Including [ftcn]
subgroups [virs]
Thought [menp]
To [qlco]
Low Risk [fndg]
Cardiovascular disease [dsyn]
Addition [ftcn]
rosuvastatin [orch, phsu]
Associated [qlco]
reductions [npop]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
reductions [npop]
APPEAR [qlco]
To [qlco]
Occur [acty]
Greatest [qnco]
Clinical [qlco]
Benefit [qnco]
Observed [ftcn]
rosuvastatin [orch, phsu]
Recipient [humn]
Level [qlco]
mmol/L [qnco]
mg dl [qnco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
mg/L [qnco]
mg/L [qnco]
rosuvastatin [orch, phsu]
Well [qlco]
Jupiter [geoa]
Trial [resa]
adverse events [fndg]
Mild to moderate [qlco]
Severity [qlco]
Myalgia [sosy]
Arthralgia [sosy]
Constipation [sosy]
Nausea [sosy]
Most [qnco]
Occur [acty]
treatment [ftcn]
adverse events [fndg]
Incidence [qnco]
monitor [hlca]
adverse events [fndg]
laboratory measurements [resa]
Similar [qlco]
rosuvastatin [orch, phsu]
placebo [topp]
Group [idcn]
Not [ftcn]
Known [qlco]
Mechanism [ftcn]
Benefit [qnco]
rosuvastatin [orch, phsu]
Lipid [lipd]
effects [qlco]
Anti-inflammatory effect [qlco]
Mixture [sbst]
rosuvastatin [orch, phsu]
Elevated [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
controversies [socb]
Drug [phsu]
Pharmacologic [bmod]
Option [ftcn]
Prevention [topp]
Cardiovascular disease [dsyn]
Efficacy [qlco]
PREVENT [phsu]
Major [qlco]
cardiovascular events [fndg]
Health [idcn]
Women [popg]
Aged [orga]
Men [popg]
Aged [orga]
Normal [qlco]
Level [qlco]
Elevated [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
